nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Multicenter Randomized Phase IIb Efficacy Study of Vx-001, a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics
|
Georgoulias, Vassilis |
|
2013 |
14 |
4 |
p. 461-465 5 p. |
artikel |
2 |
Concurrent Molecular Alterations in Tumors With Germ Line Epidermal Growth Factor Receptor T790M Mutations
|
Thomas, Anish |
|
2013 |
14 |
4 |
p. 452-456 5 p. |
artikel |
3 |
Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non–Small-Cell Lung Cancer
|
Harada, Hideyuki |
|
2013 |
14 |
4 |
p. 440-445 6 p. |
artikel |
4 |
Echinoderm Microtubule-Associated Protein-Like 4 (EML4)–Anaplastic Lymphoma Kinase (ALK) Rearrangement in Congenital Pulmonary Airway Malformation
|
Tetsumoto, Satoshi |
|
2013 |
14 |
4 |
p. 457-460 4 p. |
artikel |
5 |
Editorial Board
|
|
|
2013 |
14 |
4 |
p. A6- 1 p. |
artikel |
6 |
Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
|
Spigel, David R. |
|
2013 |
14 |
4 |
p. 356-363 8 p. |
artikel |
7 |
Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non–Small-Cell Lung Cancer
|
Sun, Hai-bo |
|
2013 |
14 |
4 |
p. 376-382 7 p. |
artikel |
8 |
Maintenance Treatment With Different Strategies in Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
|
Cai, Haoquan |
|
2013 |
14 |
4 |
p. 333-341 9 p. |
artikel |
9 |
Metastasis Dynamics for Non–Small-Cell Lung Cancer: Effect of Patient and Tumor-Related Factors
|
Kelsey, Chris R. |
|
2013 |
14 |
4 |
p. 425-432 8 p. |
artikel |
10 |
Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non–Small-Cell Lung Cancer
|
Liao, Wei-Yu |
|
2013 |
14 |
4 |
p. 418-424 7 p. |
artikel |
11 |
Nested Case Control Study of Proteomic Biomarkers for Interstitial Lung Disease in Japanese Patients With Non–Small-Cell Lung Cancer Treated With Erlotinib: A Multicenter Phase IV Study (JO21661)
|
Atagi, Shinji |
|
2013 |
14 |
4 |
p. 407-417 11 p. |
artikel |
12 |
Nutrition Habits, Physical Activity, and Lung Cancer: An Authoritative Review
|
Koutsokera, Alexandra |
|
2013 |
14 |
4 |
p. 342-350 9 p. |
artikel |
13 |
Preclinical Rationale for PI3K/Akt/mTOR Pathway Inhibitors as Therapy for Epidermal Growth Factor Receptor Inhibitor-Resistant Non–Small-Cell Lung Cancer
|
Gadgeel, Shirish M. |
|
2013 |
14 |
4 |
p. 322-332 11 p. |
artikel |
14 |
Prognostic Significance of Weight Gain During Definitive Chemoradiotherapy for Locally Advanced Non–Small-Cell Lung Cancer
|
Sher, David J. |
|
2013 |
14 |
4 |
p. 370-375 6 p. |
artikel |
15 |
Prognostic Value of Gross Tumor Volume for Definitive Radiation Therapy in Patients With Locoregionally Recurrent Non–Small-Cell Lung Cancer After Surgical Resection
|
Lee, Nam Kwon |
|
2013 |
14 |
4 |
p. 399-406 8 p. |
artikel |
16 |
Prospective Study of Urinary and Serum Cross-Linked N-Telopeptide of Type I Collagen (NTx) for Diagnosis of Bone Metastasis in Patients With Lung Cancer
|
Tamiya, Motohiro |
|
2013 |
14 |
4 |
p. 364-369 6 p. |
artikel |
17 |
Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma
|
Lau, Derick H.M. |
|
2013 |
14 |
4 |
p. 351-355 5 p. |
artikel |
18 |
Stereotactic Body Radiotherapy in Patients With Stage I Non–Small-Cell Lung Cancer Aged 75 Years and Older: Retrospective Results From a Multicenter Consortium
|
Samuels, Michael A. |
|
2013 |
14 |
4 |
p. 446-451 6 p. |
artikel |
19 |
Table of Contents
|
|
|
2013 |
14 |
4 |
p. A7-A10 nvt p. |
artikel |
20 |
The Importance of Molecular Profiling in Predicting Response to Epidermal Growth Factor Receptor Family Inhibitors in Non–Small-Cell Lung Cancer: Focus on Clinical Trial Results
|
Tsao, Anne S. |
|
2013 |
14 |
4 |
p. 311-321 11 p. |
artikel |
21 |
Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer
|
Gebbia, Vittorio |
|
2013 |
14 |
4 |
p. 390-398 9 p. |
artikel |
22 |
Tumor Burden is Predictive of Survival in Patients With Non–Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib
|
Park, Jin Hyun |
|
2013 |
14 |
4 |
p. 383-389 7 p. |
artikel |
23 |
Vitamin D Receptor Genetic Variants are Associated With Chemotherapy Response and Prognosis in Patients With Advanced Non–Small-Cell Lung Cancer
|
Xiong, Liwen |
|
2013 |
14 |
4 |
p. 433-439 7 p. |
artikel |